Status:
COMPLETED
Tight Closed-loop Systolic Arterial Pressure Control
Lead Sponsor:
Erasme University Hospital
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this case series is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard operating ...
Detailed Description
In this case series, the investigators will report the percentage of case time in hypotension (defined as systolic arterial pressure (SAP) \< 117mmHg). The target mean arterial pressure (MAP) will be ...
Eligibility Criteria
Inclusion
- Adult patients (age of \>17)
- Elective high-risk abdominal surgery
- Patients with an arterial line and in whom a goal directed fluid therapy protocol is applied manually (administration of fluid bolus to maintain a stroke volume variation \< 13%)
Exclusion
- Atrial Fibrillation
- Pregnancy
- Subjects without the capacity to give informed consent
Key Trial Info
Start Date :
September 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04357301
Start Date
September 25 2020
End Date
October 30 2020
Last Update
March 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme
Brussels, Belgium, 1070